These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20432398)

  • 1. Rotational atherectomy for fibro-calcific coronary artery disease in drug eluting stent era: procedural outcomes and angiographic follow-up results.
    Rathore S; Matsuo H; Terashima M; Kinoshita Y; Kimura M; Tsuchikane E; Nasu K; Ehara M; Asakura Y; Katoh O; Suzuki T
    Catheter Cardiovasc Interv; 2010 May; 75(6):919-27. PubMed ID: 20432398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-eluting stents versus bare metal stents following rotational atherectomy for heavily calcified coronary lesions: late angiographic and clinical follow-up results.
    Khattab AA; Otto A; Hochadel M; Toelg R; Geist V; Richardt G
    J Interv Cardiol; 2007 Apr; 20(2):100-6. PubMed ID: 17391217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of rotational atherectomy for the implantation of drug-eluting stents in the calcified lesions of hemodialysis patients.
    Fujimoto H; Ishiwata S; Yamaguchi T; Ohno M
    J Cardiol; 2010 Mar; 55(2):232-7. PubMed ID: 20206077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirolimus-eluting stents and calcified coronary lesions: clinical outcomes of patients treated with and without rotational atherectomy.
    Clavijo LC; Steinberg DH; Torguson R; Kuchulakanti PK; Chu WW; Fournadjiev J; Satler LF; Kent KM; Suddath WO; Waksman R; Pichard AD
    Catheter Cardiovasc Interv; 2006 Dec; 68(6):873-8. PubMed ID: 17086529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of elective stent implantation following rotational atherectomy in large calcified coronary arteries.
    Hong MK; Mintz GS; Popma JJ; Kent KM; Pichard AD; Satler LF; Wong C; Brahimi A; Bucher T; Leon MB
    Cathet Cardiovasc Diagn; 1996; Suppl 3():50-4. PubMed ID: 8874928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stenting alone versus debulking and debulking plus stent in branch ostial lesions of native coronary arteries.
    Chung CM; Nakamura S; Tanaka K; Tanigawa J; Kitano K; Akiyama T; Matoba Y; Katoh O
    Heart Vessels; 2004 Sep; 19(5):213-20. PubMed ID: 15372295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of fractional flow reserve in the treatment of a calcific bifurcation left anterior descending coronary stenosis with rotational atherectomy.
    Holmes DG; Kern MJ
    Catheter Cardiovasc Interv; 2001 May; 53(1):64-7. PubMed ID: 11329220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Safety and efficacy of rotational atherectomy followed by drug-eluting stenting for treating patients with heavily calcified coronary lesions].
    Li Q; Liu J; Lu MY; Ma YL; Zhao H; Ding RJ; Liu CF; Wang WM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Jun; 41(6):457-61. PubMed ID: 24113035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rotational atherectomy in the drug-eluting stent era: a single-center experience.
    Schwartz BG; Mayeda GS; Economides C; Kloner RA; Shavelle DM; Burstein S
    J Invasive Cardiol; 2011 Apr; 23(4):133-9. PubMed ID: 21474844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-eluting stents following rotational atherectomy for heavily calcified coronary lesions: long-term clinical outcomes.
    Benezet J; Díaz de la Llera LS; Cubero JM; Villa M; Fernández-Quero M; Sánchez-González A
    J Invasive Cardiol; 2011 Jan; 23(1):28-32. PubMed ID: 21183767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rotational atherectomy is useful to treat restenosis lesions due to crushing of a sirolimus-eluting stent implanted in severely calcified lesions: experimental study and initial clinical experience.
    Okamura A; Ito H; Fujii K
    J Invasive Cardiol; 2009 Oct; 21(10):E191-6. PubMed ID: 19805850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-hospital and mid-term outcomes of stent implantation in patients with protected and unprotected left main coronary artery disease; King Chulalongkorn Memorial Hospital experiences.
    Cholteesupachai J; Udayachalerm W; Srimahachota S; Buddhari W; Chaipromprasit J; Songmuang SB; Suithichaiyakul T
    J Med Assoc Thai; 2009 Jun; 92(6):755-60. PubMed ID: 19530580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical outcomes of rotational atherectomy followed by drug-eluting stenting via the transradial approach for the treatment of heavily calcified coronary lesions].
    Cui JG; Yang YJ; Wu YJ; Qiao SB; Xu B; Yuan JQ; Chen J; Liu HB; You SJ; Hu FH; Qian J; Dou KF; Gao Z; Qiu H; Zhao J; Chen JL; Gao RL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Jun; 41(6):462-5. PubMed ID: 24113036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of clinical and angiographic outcomes after Excel bioabsorbable polymer versus Firebird durable polymer rapamycin-eluting stent for the treatment of coronary artery disease in a "real world" setting: six-month follow-up results.
    Liu HB; Xu B; Qiao SB; Yang YJ; Ma WH; Qin XW; Yao M; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Li JJ; Chen JL; Gao RL
    Chin Med J (Engl); 2007 Apr; 120(7):574-7. PubMed ID: 17442205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary in-stent restenosis in diabetic patients after implantation of sirolimus or paclitaxel drug-eluting coronary stents.
    Kitoga M; Pasquet A; Preumont V; Kefer J; Hermans MP; Vanoverschelde JL; Buysschaert M
    Diabetes Metab; 2008 Feb; 34(1):62-7. PubMed ID: 18069029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients.
    Dibra A; Kastrati A; Mehilli J; Pache J; Schühlen H; von Beckerath N; Ulm K; Wessely R; Dirschinger J; Schömig A;
    N Engl J Med; 2005 Aug; 353(7):663-70. PubMed ID: 16105990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of bare-metal and sirolimus- or paclitaxel-eluting stents for aorto-ostial coronary disease.
    Barlis P; Kaplan S; Dimopoulos K; Ferrante G; Di Mario C
    Cardiology; 2008; 111(4):270-6. PubMed ID: 18451644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update in management of coronary bifurcation lesions in the drug-eluting stent era.
    Sharma SK
    Indian Heart J; 2006; 58(2):108-19. PubMed ID: 18989054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents.
    Kastrati A; Dibra A; Mehilli J; Mayer S; Pinieck S; Pache J; Dirschinger J; Schömig A
    Circulation; 2006 May; 113(19):2293-300. PubMed ID: 16682614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.